- Very limited direct evidence: No well-designed clinical trials have specifically tested valerian root for IBS symptoms; most gut-related research involves combination herbal products.
- Theoretical rationale exists: Valerian's sedative and smooth-muscle-relaxing properties are plausible mechanisms for IBS discomfort, but plausibility is not proof.
- Better-supported options are available: Peppermint oil and gut-directed cognitive behavioral therapy have far stronger evidence bases for IBS symptom relief.
- Not risk-free: Valerian interacts with sedatives, and safety data in pregnancy and liver disease is insufficient — these groups should avoid it.
What the evidence shows
If you're searching for a clean answer here, the honest one is: we don't really know whether valerian helps IBS. There are no randomized controlled trials that have enrolled IBS patients and tested valerian root as a standalone intervention against a placebo. That absence is itself informative — valerian has been used in herbal medicine for centuries, and if the signal were obvious, researchers would have chased it by now.
What does exist is indirect evidence. Valerian appears repeatedly in multi-herb preparations marketed for digestive discomfort. One older German study investigated a combination product containing valerian alongside other antispasmodic herbs and found modest improvements in cramping and bloating, but the design made it impossible to attribute any benefit to valerian specifically (Melzer et al., 2004). Combination studies tell us about the cocktail, not the ingredient.
For anxiety-related aspects of IBS — and anxiety is tightly bound to gut symptom severity through the gut-brain axis — valerian has slightly more data. A meta-analysis of valerian for general anxiety and sleep found small but statistically significant reductions in anxiety scores in some trials, though the overall evidence quality was rated low to moderate (Shinjyo et al., 2020). Since anxiety amplifies visceral hypersensitivity in IBS (Fond et al., 2014), calming the nervous system could theoretically take some edge off symptom flares. But "theoretically" is doing a lot of work in that sentence.
Compare this to peppermint oil, which has been tested in multiple well-designed IBS trials. A 2019 meta-analysis of 12 randomized controlled trials found peppermint oil significantly superior to placebo for overall IBS symptoms and abdominal pain (Alammar et al., 2019). That is the kind of evidence valerian simply does not have for IBS.
How it works (mechanism)
Valerian root (Valeriana officinalis) contains compounds — including valerenic acid and isovaleric acid — that appear to modulate GABA-A receptors, the same inhibitory receptors targeted by benzodiazepines, though with much weaker effect (Benke et al., 2009). GABA activity in the enteric nervous system (the gut's own neural network) can reduce smooth muscle contractility and dampen pain signaling. In theory, this could ease the cramping and urgency that characterize IBS.
Valerian also shows some evidence of calcium channel antagonism in smooth muscle tissue in animal models, which could further reduce intestinal spasm (Ortiz et al., 1999). Again, animal pharmacology and human clinical benefit are two very different things, and the gap between them is where most promising supplements ultimately stall.
Dose & timing if you try it
Because no IBS-specific dosing studies exist, any guidance here is extrapolated from the anxiety and sleep literature — the populations in whom valerian has been most studied.
- Typical studied dose: 300–600 mg of standardized dry root extract (standardized to 0.8% valerenic acids), taken once daily in the evening or divided into two doses.
- Onset: Consistent effects in anxiety trials generally required 2–4 weeks of daily use; don't expect immediate relief (Shinjyo et al., 2020).
- Form: Capsule or tablet preparations with standardized valerenic acid content are preferable to teas or tinctures, where dose is unpredictable.
- Timing for IBS: Given valerian's sedating properties, taking it in the evening may help with overnight gut motility issues or sleep disruption that worsens next-day symptoms — though this is speculative.
If you experiment, track symptoms for at least four weeks before judging effect. And be candid with yourself: if you see no meaningful change after a month, there's no strong evidence to justify continuing.
Who should skip
- Pregnant and breastfeeding individuals: Safety data is absent; animal studies have raised developmental concerns. Avoid.
- People taking sedatives, benzodiazepines, or alcohol: Additive CNS depression is a real risk. Do not combine without medical supervision.
- Anyone on CYP3A4-metabolized medications: In vitro evidence suggests valerian may inhibit this liver enzyme, potentially altering drug levels (Lefebvre et al., 2004). Discuss with a pharmacist if you take statins, certain antihistamines, or immunosuppressants.
- People with pre-existing liver conditions: Rare cases of hepatotoxicity have been reported with valerian-containing products; causality is unclear but caution is warranted (MacGregor et al., 1989).
- Children under 12: Insufficient safety data.
- Anyone scheduled for surgery: Discontinue at least two weeks prior due to potential sedative interaction with anesthesia.
Bottom line
Valerian for IBS is an idea looking for evidence, not a treatment backed by it. The pharmacological rationale is coherent — GABA modulation and smooth muscle relaxation are legitimate targets in IBS pathophysiology — but good intentions and a plausible mechanism do not substitute for clinical trial data. Right now, that data does not exist.
If your IBS is driven significantly by stress and anxiety, valerian might provide modest indirect benefit via its nervous system effects, but gut-directed hypnotherapy, cognitive behavioral therapy, and low-FODMAP dietary intervention all have substantially stronger evidence and no drug interaction profiles to worry about (Lacy et al., 2021).
If you are curious about herbal options with actual IBS trial data, enteric-coated peppermint oil is a far more defensible starting point. Valerian is not something we'd recommend prioritizing until researchers run the trials needed to settle the question.
References
- Alammar N, et al. The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data. BMC Complementary and Alternative Medicine. 2019;19(1):21.
- Benke D, et al. GABAA receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts. Neuropharmacology. 2009;56(1):174–181.
- Fond G, et al. Anxiety and depression comorbidities in irritable bowel syndrome: a systematic review and meta-analysis. European Archives of Psychiatry and Clinical Neuroscience. 2014;264(8):651–660.
- Lacy BE, et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. American Journal of Gastroenterology. 2021;116(1):17–44.
- Lefebvre T, et al. In vitro activity of valerian constituents on CYP3A4. Phytomedicine. 2004;11(2–3):98–104.
- MacGregor FB, et al. Hepatotoxicity of herbal remedies. BMJ. 1989;299(6708):1156–1157.
- Melzer J, et al. Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast). Alimentary Pharmacology & Therapeutics. 2004;20(11–12):1279–1287.
- Ortiz JG, et al. Effects of Valeriana officinalis extracts on [3H]flunitrazepam binding. Neurochemical Research. 1999;24(11):1373–1378.
- Shinjyo N, et al. Valerian root in treating sleep problems and associated disorders — a systematic review and meta-analysis. Journal of Evidence-Based Integrative Medicine. 2020;25:2515690X20967323.
- Note: Direct high-quality RCT evidence for valerian specifically in IBS is absent from the published literature as of this writing. The references above support adjacent claims (mechanism, anxiety, IBS management guidelines). Readers should interpret the evidence accordingly.